Safety, Tolerability, and Pharmacokinetics, of Single and Multiple Ascending Doses of FP-020 in Healthy Adult Volunteers
NCT06334211
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
64
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
FP-020
OTHER:
placebo
Sponsor
Foresee Pharmaceuticals Co., Ltd.
Collaborators
[object Object]